• India
  • +91 98480 35983
  • India
  • USA
  • +1-408-508-5432
  • USA
  • Australia
  • +61-405-871-726
  • Australia
  • or
  • D-U-N-S : 854321383
  • LEI : 9845004484A1C4C82E71
  • MSME : UDYAM-TS-02-0059615

Rushi Pharma provides structured Quality and Regulatory advisory support in collaboration with experienced regulatory professionals to assist pharmaceutical companies in meeting global compliance standards.

Regulatory & CMC Support:

  • Review of Chemistry, Manufacturing & Controls (CMC) for NCEs and NMEs
  • Regulatory documentation strategy support
  • Development Quality Assurance guidance
  • QbD (Quality by Design) consultation
  • CAPA management frameworks

Facility Qualification & Compliance:

  • Design, review, and qualification of manufacturing facilities
  • Laboratory and packaging unit assessment
  • Gap analysis against cGMP expectations
  • Remediation planning for QA/RA compliance
  • Technology transfer oversight
  • Exhibit batch execution guidance

Audit & Due Diligence Support:

  • For-cause audits
  • Due diligence audits
  • Clinical audits (GCP)
  • Compliance risk assessment
  • D-U-N-S: 854321383
  • LEI: 9845004484A1C4C82E71
  • MSME UDYAM-TS-02-0059615
Scroll To Top